| 1 | Lymphoma | 34% |
| 2 | Angiomyolipoma | 30.1% |
| 3 | lymphangiosarcoma | 27% |
| 4 | Composite Lymphoma | 26% |
| 5 | Sezary Syndrome | 23.3% |
| 6 | Tumor Lysis Syndrome | 22.8% |
| 7 | Chondrosarcoma | 21.5% |
| 8 | leiomyosarcoma | 21.5% |
| 9 | liposarcoma | 21.5% |
| 10 | synovial sarcoma | 21.5% |
| 11 | Clear Cell Sarcoma of Soft Tissue | 21.5% |
| 12 | Alveolar Soft Part Sarcoma | 21.5% |
| 13 | Histiocytic Disorders, Malignant | 21.4% |
| 14 | Hodgkin Disease | 21.3% |
| 15 | Lymphoma, Non-Hodgkin | 21.3% |
| 16 | Plasmacytoma | 21.2% |
| 17 | Carcinosarcoma | 20.5% |
| 18 | Hemangiosarcoma | 20.5% |
| 19 | Leukemia, Plasma Cell | 20.4% |
| 20 | leukemia | 19.7% |
| 21 | Neoplasms, Germ Cell and Embryonal | 19.7% |
| 22 | Neoplasms, Glandular and Epithelial | 19.7% |
| 23 | Germ Cell Cancer | 19.7% |
| 24 | Primary amyloidosis | 19.6% |
| 25 | Autoimmune Lymphoproliferative Syndrome | 19.6% |
| 26 | Neuroectodermal Tumors | 19.6% |
| 27 | Lymphangioma | 19.5% |
| 28 | Sarcoma | 19.5% |
| 29 | Neoplasms, Neuroepithelial | 19.4% |
| 30 | Gliomatosis cerebri | 19.4% |
| 31 | Fibrosarcoma | 18.8% |
| 32 | Osteosarcoma | 18.8% |
| 33 | Leukemia, T-Cell | 18.4% |
| 34 | Leukemia, B-Cell | 18.4% |
| 35 | Infectious Mononucleosis | 18.4% |
| 36 | Malignant Fibrous Histiocytoma | 17.4% |
| 37 | Carcinoma 256, Walker | 17.2% |
| 38 | Sarcoma, Myeloid | 17.2% |
| 39 | Waldenstrom Macroglobulinemia | 17% |
| 40 | Multiple Myeloma | 17% |
| 41 | melanoma | 16.6% |
| 42 | Rhabdomyosarcoma | 16% |
| 43 | Giant Cell Tumor of Bone | 16% |
| 44 | Meningioma | 15.8% |
| 45 | Medulloblastoma | 15.3% |
| 46 | Lymphoma, Follicular | 15.1% |
| 47 | T-Cell Lymphoma | 15.1% |
| 48 | Mantle cell lymphoma | 15.1% |
| 49 | Heavy Chain Disease | 14.9% |
| 50 | Lymphomatoid Granulomatosis | 14.8% |
| 51 | Dermatofibrosarcoma | 14.7% |
| 52 | Dermatofibrosarcoma Protuberans | 14.7% |
| 53 | Thymoma | 14.4% |
| 54 | Sarcoma, Experimental | 14% |
| 55 | Lymphocele | 13.9% |
| 56 | Adenoma, Acidophil | 13.8% |
| 57 | Ganglioneuroma | 13.8% |
| 58 | Glioma | 13.8% |
| 59 | Malignant Glioma | 13.8% |
| 60 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 13.7% |
| 61 | Leukemia, Large Granular Lymphocytic | 13.7% |
| 62 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 13.7% |
| 63 | Agammaglobulinemia | 13.7% |
| 64 | Sarcoidosis | 13.6% |
| 65 | Melanoma, Experimental | 13.3% |
| 66 | Alveolar rhabdomyosarcoma | 13.3% |
| 67 | Endometrial Stromal Sarcoma | 13.2% |
| 68 | Trophoblastic Neoplasms | 13.2% |
| 69 | Leukemia, Experimental | 13.1% |
| 70 | Adenofibroma | 13.1% |
| 71 | Fibroadenoma | 13.1% |
| 72 | Malignant histiocytosis | 13% |
| 73 | Histiocytic sarcoma | 13% |
| 74 | Neurofibrosarcoma | 12.9% |
| 75 | Basal cell carcinoma | 12.9% |
| 76 | Carcinoma, Papillary | 12.9% |
| 77 | Squamous cell carcinoma | 12.9% |
| 78 | Craniopharyngioma | 12.9% |
| 79 | Cystadenoma | 12.9% |
| 80 | Phyllodes Tumor | 12.9% |
| 81 | Lipoma | 12.9% |
| 82 | Mesothelioma | 12.9% |
| 83 | Myoma | 12.9% |
| 84 | Myxoma | 12.9% |
| 85 | Neuroectodermal Tumor, Melanotic | 12.9% |
| 86 | Angiolipoma | 12.9% |
| 87 | Myelolipoma | 12.9% |
| 88 | Neoplasms, Bone Tissue | 12.9% |
| 89 | Neoplasms, Fibrous Tissue | 12.9% |
| 90 | Smooth Muscle Tumor | 12.9% |
| 91 | Neuroendocrine Tumors | 12.9% |
| 92 | Desmoplastic Small Round Cell Tumor | 12.9% |
| 93 | Chondroma | 12.9% |
| 94 | Enchondroma | 12.9% |
| 95 | Carcinoma, Basal Cell | 12.9% |
| 96 | Carcinoid Tumor | 12.4% |
| 97 | Neurilemmoma | 12.4% |
| 98 | Hutchinson's Melanotic Freckle | 12.4% |
| 99 | Melanoma, Amelanotic | 12.4% |
| 100 | Hamartoma | 12.2% |
| 101 | Neoplasms, Hormone-Dependent | 12.2% |
| 102 | Neoplasms, Multiple Primary | 12.2% |
| 103 | Paraneoplastic Syndromes | 12.2% |
| 104 | Precancerous Conditions | 12.2% |
| 105 | Neoplasms, Second Primary | 12.2% |
| 106 | Lymphoma, T-Cell, Cutaneous | 12.1% |
| 107 | Lymphoma, AIDS-Related | 12.1% |
| 108 | Enteropathy-Associated T-Cell Lymphoma | 12.1% |
| 109 | Primary Effusion Lymphoma | 12.1% |
| 110 | Carcinoma, Ehrlich Tumor | 12% |
| 111 | Dermoid Cyst | 12% |
| 112 | Carcinoma, Lewis Lung | 12% |
| 113 | Adenoma | 11.7% |
| 114 | Ameloblastoma | 11.7% |
| 115 | Angiokeratoma | 11.7% |
| 116 | Carcinoma | 11.7% |
| 117 | Chordoma | 11.7% |
| 118 | Hemangioma | 11.7% |
| 119 | hemangiopericytoma | 11.7% |
| 120 | Mesenchymoma | 11.7% |
| 121 | Nevus | 11.7% |
| 122 | Teratoma | 11.7% |
| 123 | Hepatoblastoma | 11.7% |
| 124 | Mixed Tumor, Mullerian | 11.7% |
| 125 | Germinoma | 11.7% |
| 126 | Teratocarcinoma | 11.7% |
| 127 | Angiofibroma | 11.7% |
| 128 | Epithelioma | 11.7% |
| 129 | Leukemia, Radiation-Induced | 11.6% |
| 130 | Granuloma | 11.5% |
| 131 | Thymus Neoplasms | 11.5% |
| 132 | Sarcoma 180 | 11.3% |
| 133 | Cystadenocarcinoma | 11.3% |
| 134 | Mucoepidermoid Carcinoma | 11.3% |
| 135 | Astrocytoma | 11% |
| 136 | Ependymoma | 11% |
| 137 | oligodendroglioma | 11% |
| 138 | Ganglioglioma | 11% |
| 139 | gliosarcoma | 11% |
| 140 | Anaplastic astrocytoma | 11% |
| 141 | Anaplastic Oligodendroglioma | 11% |
| 142 | Choriocarcinoma | 10.9% |
| 143 | Carcinoma, Lobular | 10.9% |
| 144 | Mastocytosis | 10.8% |
| 145 | Mycosis Fungoides | 10.6% |
| 146 | Lymphomatoid Papulosis | 10.6% |
| 147 | Plasmablastic lymphoma | 10.6% |
| 148 | Splenic Neoplasms | 10.4% |
| 149 | Malignant Carcinoid Syndrome | 10.3% |
| 150 | Cyst | 10.2% |
| 151 | Neoplastic Processes | 10.2% |
| 152 | Neoplastic Syndromes, Hereditary | 10.2% |
| 153 | Pregnancy Complications, Neoplastic | 10.2% |
| 154 | Neoplasms, Experimental | 10.1% |
| 155 | Retinoblastoma | 10.1% |
| 156 | Paraproteinemias | 9.9% |
| 157 | Adenitis | 9.9% |
| 158 | Histiocytosis | 9.9% |
| 159 | Lymphadenitis | 9.9% |
| 160 | Lymphangitis | 9.9% |
| 161 | Lymphedema | 9.9% |
| 162 | Splenic Diseases | 9.9% |
| 163 | Thymus Hyperplasia | 9.9% |
| 164 | Pseudolymphoma | 9.9% |
| 165 | Lymphadenopathy | 9.9% |
| 166 | Leukemia L1210 | 9.7% |
| 167 | Leukemia P388 | 9.7% |
| 168 | Acanthoma | 9.7% |
| 169 | Multiple Endocrine Neoplasia | 9.7% |
| 170 | fibroma | 9.6% |
| 171 | Fibromatosis | 9.6% |
| 172 | Osteoblastoma | 9.6% |
| 173 | Osteoma | 9.6% |
| 174 | Rhabdomyoma | 9.6% |
| 175 | Chondromatosis | 9.6% |
| 176 | Bowen's Disease | 9.6% |
| 177 | Paraganglioma | 9.6% |
| 178 | Glioblastoma | 9.6% |
| 179 | Neuroblastoma | 9.6% |
| 180 | Glioblastoma Multiforme | 9.6% |
| 181 | Burkitt Lymphoma | 9.5% |
| 182 | Gastrointestinal Stromal Tumors | 9.3% |
| 183 | Mastocytosis, Systemic | 9.1% |
| 184 | Monoclonal Gammopathy of Undetermined Significance | 8.9% |
| 185 | Ganglioneuroblastoma | 8.9% |
| 186 | Neoplasms, Radiation-Induced | 8.7% |
| 187 | Hypergammaglobulinemia | 8.6% |
| 188 | Nephroblastoma | 8.4% |
| 189 | Lymphangiectasis, Intestinal | 8.4% |
| 190 | Hematologic Neoplasms | 8.3% |
| 191 | Lymphatic Abnormalities | 8.3% |
| 192 | Carcinoid Heart Disease | 8.2% |
| 193 | Mastocytoma | 8.1% |
| 194 | Fibromatosis, Aggressive | 8% |
| 195 | Fibromatosis, Abdominal | 8% |
| 196 | Pheochromocytoma | 8% |
| 197 | Transfusion Reaction | 8% |
| 198 | Hypotensive Transfusion Reaction | 8% |
| 199 | Basal Cell Nevus Syndrome | 7.8% |
| 200 | Adenocarcinoma | 7.7% |
| 201 | Carcinoma in Situ | 7.7% |
| 202 | Carcinoma, Transitional Cell | 7.7% |
| 203 | Dysgerminoma | 7.7% |
| 204 | Hemangioendothelioma | 7.7% |
| 205 | Neuroma | 7.7% |
| 206 | Papilloma | 7.7% |
| 207 | Pseudomyxoma Peritonei | 7.7% |
| 208 | Seminoma | 7.7% |
| 209 | Papillomatosis | 7.7% |
| 210 | Adenomatosis, Pulmonary | 7.7% |
| 211 | Adenomatous Polyps | 7.7% |
| 212 | Carcinoma, Large Cell | 7.7% |
| 213 | Carcinoma, Small Cell | 7.7% |
| 214 | Tuberous Sclerosis | 7.7% |
| 215 | Paraneoplastic Encephalomyelitis | 7.6% |
| 216 | Sarcoidosis, Pulmonary | 7.6% |
| 217 | Leukemia, Myelomonocytic, Chronic | 7.5% |
| 218 | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 7.5% |
| 219 | Mammary Neoplasms, Experimental | 7.5% |
| 220 | Acoustic Neuroma | 7.4% |
| 221 | Carcinoma, Pancreatic Ductal | 7.2% |
| 222 | Mucocutaneous Lymph Node Syndrome | 7.1% |
| 223 | Mesoblastic Nephroma | 6.8% |
| 224 | Optic Nerve Glioma | 6.8% |
| 225 | Abdominal Neoplasms | 6.6% |
| 226 | Erythroplasia | 6.6% |
| 227 | Follicular cyst | 6.6% |
| 228 | Head and Neck Neoplasms | 6.6% |
| 229 | Mucocele | 6.6% |
| 230 | Pilonidal Cyst | 6.6% |
| 231 | Soft Tissue Neoplasms | 6.6% |
| 232 | Thoracic Neoplasms | 6.6% |
| 233 | Thyroglossal Cyst | 6.6% |
| 234 | Synovial Cyst | 6.6% |
| 235 | Aberrant Crypt Foci | 6.6% |
| 236 | Hepatocellular Adenoma | 6.5% |
| 237 | Hemangioma, Cavernous | 6.5% |
| 238 | Vipoma | 6.1% |
| 239 | Autoimmune Diseases | 6.1% |
| 240 | Hypersensitivity | 6.1% |
| 241 | Immunologic Deficiency Syndromes | 6.1% |
| 242 | Immune reconstitution syndrome | 6.1% |
| 243 | Immune Reconstitution Inflammatory Syndrome | 6.1% |
| 244 | Hydatidiform Mole | 6% |
| 245 | Dupuytren Contracture | 5.8% |
| 246 | Elephantiasis | 5.8% |
| 247 | Hypersplenism | 5.8% |
| 248 | Elephantiasis Nostras Verrucosa | 5.8% |
| 249 | Multiple Endocrine Neoplasia Type 1 | 5.8% |
| 250 | Adenoid Cystic Carcinoma | 5.8% |
| 251 | Adenocarcinoma, Clear Cell | 5.8% |
| 252 | Cholangiocarcinoma | 5.8% |
| 253 | Cervical Intraepithelial Neoplasia | 5.8% |
| 254 | Hemangioblastoma | 5.8% |
| 255 | Lymphoma, Extranodal NK-T-Cell | 5.8% |
| 256 | Urticaria Pigmentosa | 5.8% |
| 257 | Prolactinoma | 5.8% |
| 258 | Growth Hormone-Secreting Pituitary Adenoma | 5.8% |
| 259 | Digestive System Neoplasms | 5.7% |
| 260 | Endocrine Gland Neoplasms | 5.7% |
| 261 | Eye Neoplasms | 5.7% |
| 262 | Nervous System Neoplasms | 5.7% |
| 263 | Sturge-Weber Syndrome | 5.6% |
| 264 | Leukemia, Myeloid, Chronic-Phase | 5.6% |
| 265 | Bone Marrow Neoplasms | 5.6% |
| 266 | Bone neoplasms | 5.6% |
| 267 | Leukoplakia | 5.6% |
| 268 | Pancreatic Cyst | 5.6% |
| 269 | Skin Neoplasms | 5.6% |
| 270 | neurofibroma | 5.5% |
| 271 | Barrett Esophagus | 5.5% |
| 272 | Breast Cyst | 5.5% |
| 273 | Actinic keratosis | 5.5% |
| 274 | Mediastinal Cyst | 5.5% |
| 275 | Neoplasm Invasiveness | 5.5% |
| 276 | Neoplasm Metastasis | 5.5% |
| 277 | Neoplasm Recurrence, Local | 5.5% |
| 278 | Parovarian Cyst | 5.5% |
| 279 | Pericardial Cyst | 5.5% |
| 280 | Thymic Cyst | 5.5% |
| 281 | Carcinogenesis | 5.5% |
| 282 | Myxoid cyst | 5.5% |
| 283 | Metastasis | 5.5% |
| 284 | Adenomatous Polyposis Coli | 5.3% |
| 285 | Cryoglobulinemia | 5.3% |
| 286 | granulosa cell tumor | 5.2% |
| 287 | Carcinoma, Ovarian Epithelial | 5.2% |
| 288 | Liver Neoplasms, Experimental | 5.1% |
| 289 | Parathyroid Neoplasms | 5% |
| 290 | Peritoneal Neoplasms | 5% |
| 291 | Thyroid Neoplasm | 5% |
| 292 | Thyroid carcinoma | 5% |
| 293 | Splenic Infarction | 4.9% |
| 294 | Histiocytosis, Langerhans-Cell | 4.9% |
| 295 | Lymphangioleiomyomatosis | 4.8% |
| 296 | insulinoma | 4.8% |
| 297 | Klatskin Tumor | 4.8% |
| 298 | Autoimmune thrombocytopenia | 4.7% |
| 299 | Immune thrombocytopenic purpura | 4.7% |
| 300 | Corpus Luteum Cyst | 4.7% |
| 301 | Ovarian Cysts | 4.7% |
| 302 | Thrombocytopenic purpura | 4.6% |
| 303 | Pancreatic Neoplasm | 4.5% |
| 304 | POEMS Syndrome | 4.5% |
| 305 | Gastrinoma | 4.3% |
| 306 | Glucagonoma | 4.3% |
| 307 | Lambert-Eaton Myasthenic Syndrome | 4.3% |
| 308 | Splenic Rupture | 4.3% |
| 309 | Adrenocortical carcinoma | 4.3% |
| 310 | Glomerulonephritis, Membranoproliferative | 4.3% |
| 311 | Nasopharyngeal carcinoma | 4.2% |
| 312 | Leydig Cell Tumor | 4.2% |
| 313 | Disseminated Intravascular Coagulation | 4.2% |
| 314 | Protein S Deficiency | 4.2% |
| 315 | Choledochal Cyst | 4.2% |
| 316 | Tracheal Neoplasms | 4.1% |
| 317 | Denys-Drash Syndrome | 4.1% |
| 318 | Peutz-Jeghers Syndrome | 4.1% |
| 319 | Leukoplakia, Oral | 4.1% |
| 320 | Paraneoplastic Cerebellar Degeneration | 4.1% |
| 321 | Polycythemia Vera | 4% |
| 322 | Retroperitoneal Neoplasms | 3.9% |
| 323 | Lymphohistiocytosis, Hemophagocytic | 3.9% |
| 324 | Schnitzler Syndrome | 3.9% |
| 325 | Erdheim-Chester Disease | 3.9% |
| 326 | Thrombocythemia, Essential | 3.9% |
| 327 | Renal Cell Carcinoma | 3.8% |
| 328 | Papillary Renal Cell Carcinoma | 3.8% |
| 329 | Lymphopenia | 3.8% |
| 330 | Transfusion-Related Acute Lung Injury | 3.8% |
| 331 | Carcinoma, Endometrioid | 3.7% |
| 332 | Esophageal Neoplasms | 3.6% |
| 333 | Limbic Encephalitis | 3.6% |
| 334 | Testicular Neoplasms | 3.3% |
| 335 | Mouth Neoplasms | 3.3% |
| 336 | Central Nervous System Neoplasms | 3.3% |
| 337 | Vascular Neoplasms | 3.3% |
| 338 | Anemia | 3.3% |
| 339 | Blood Coagulation Disorders | 3.3% |
| 340 | Blood Platelet Disorders | 3.3% |
| 341 | Bone Marrow Diseases | 3.3% |
| 342 | Hemorrhagic Disorders | 3.3% |
| 343 | Immune Complex Diseases | 3.3% |
| 344 | Leukocyte Disorders | 3.3% |
| 345 | Methemoglobinemia | 3.3% |
| 346 | Pancytopenia | 3.3% |
| 347 | Polycythemia | 3.3% |
| 348 | Sulfhemoglobinemia | 3.3% |
| 349 | Antiphospholipid Syndrome | 3.3% |
| 350 | Thrombophilia | 3.3% |
| 351 | Latex allergy | 3.3% |
| 352 | Erythrocytosis | 3.3% |
| 353 | Thrombasthenia | 3.3% |
| 354 | Antithrombin III Deficiency | 3.3% |
| 355 | Protein C Deficiency | 3.3% |
| 356 | Genital Neoplasms, Female | 3.3% |
| 357 | Myelitis, Transverse | 3.3% |
| 358 | Pancreatic Pseudocyst | 3.3% |
| 359 | Thyroid Nodule | 3.3% |
| 360 | Lymphatic Metastasis | 3.2% |
| 361 | Neoplasms, Unknown Primary | 3.2% |
| 362 | Leukemic Infiltration | 3.2% |
| 363 | Breast Neoplasms, Male | 3.2% |
| 364 | Neoplasm Micrometastasis | 3.2% |
| 365 | Triple Negative Breast Neoplasms | 3.2% |
| 366 | Wiskott-Aldrich Syndrome | 3.1% |
| 367 | Opsoclonus-Myoclonus Syndrome | 3% |
| 368 | Eosinophilic Granuloma | 2.9% |
| 369 | Adrenal Gland Neoplasms | 2.9% |
| 370 | Gastrointestinal Neoplasms | 2.9% |
| 371 | Genital Neoplasms, Male | 2.9% |
| 372 | Liver neoplasms | 2.9% |
| 373 | Uveal Neoplasms | 2.9% |
| 374 | Afibrinogenemia | 2.8% |
| 375 | Factor VII Deficiency | 2.8% |
| 376 | Factor X Deficiency | 2.8% |
| 377 | Factor XII Deficiency | 2.8% |
| 378 | Hemophilia A | 2.8% |
| 379 | Activated Protein C Resistance | 2.8% |
| 380 | Factor II deficiency | 2.8% |
| 381 | Factor VIII Deficiency | 2.8% |
| 382 | Factor V deficiency | 2.8% |
| 383 | Factor XI Deficiency | 2.8% |
| 384 | Hypoprothrombinemias | 2.8% |
| 385 | Environmental Illness | 2.8% |
| 386 | Urologic Neoplasms | 2.8% |
| 387 | Hydrops Fetalis | 2.8% |
| 388 | Sebaceous Gland Neoplasms | 2.8% |
| 389 | Spinal Neoplasms | 2.8% |
| 390 | Splenosis | 2.8% |
| 391 | Vitamin K Deficiency | 2.8% |
| 392 | Lupus Erythematosus, Systemic | 2.8% |
| 393 | Pregnancy Complications, Hematologic | 2.8% |
| 394 | Overlap syndrome | 2.8% |
| 395 | Polycystic Ovary Syndrome | 2.8% |
| 396 | Xeroderma Pigmentosum | 2.8% |
| 397 | Addison Disease | 2.7% |
| 398 | Pemphigus | 2.7% |
| 399 | Autoimmune thyroiditis | 2.7% |
| 400 | Primary Adrenal Insufficiency | 2.7% |
| 401 | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 2.7% |
| 402 | Autoimmune hepatitis | 2.7% |
| 403 | Thrombocytosis | 2.7% |
| 404 | Job Syndrome | 2.7% |
| 405 | Kernicterus | 2.6% |
| 406 | Nose Neoplasms | 2.4% |
| 407 | Latent Autoimmune Diabetes in Adults | 2.4% |
| 408 | Dermatitis Herpetiformis | 2.4% |
| 409 | Kounis Syndrome | 2.4% |
| 410 | HIV Infections | 2.3% |
| 411 | Chronic granulomatous disease | 2.3% |
| 412 | Palatal Neoplasms | 2.3% |
| 413 | Pituitary Adenoma | 2.2% |
| 414 | Pituitary Neoplasms | 2.2% |
| 415 | Asthma, Aspirin-Induced | 2.2% |
| 416 | ovarian neoplasm | 2.2% |
| 417 | Meningeal Neoplasms | 2.2% |
| 418 | Hemoglobinuria, Paroxysmal | 2.2% |
| 419 | Leukemoid Reaction | 2.2% |
| 420 | Rheumatoid Arthritis | 2.1% |
| 421 | Juvenile arthritis | 2.1% |
| 422 | Graves Disease | 2.1% |
| 423 | Purpura, Thrombotic Thrombocytopenic | 2.1% |
| 424 | Anti-Glomerular Basement Membrane Disease | 2% |
| 425 | Serum Sickness | 2% |
| 426 | Anemia, Diamond-Blackfan | 2% |
| 427 | anaphylaxis | 1.9% |
| 428 | Anemia, Hemolytic | 1.9% |
| 429 | Anemia, Macrocytic | 1.9% |
| 430 | Eosinophilia | 1.9% |
| 431 | Food Allergy | 1.9% |
| 432 | Hypoproteinemia | 1.9% |
| 433 | Leukopenia | 1.9% |
| 434 | Thrombocytopenia | 1.9% |
| 435 | Leukostasis | 1.9% |
| 436 | MYELODYSPLASTIC SYNDROME | 1.9% |
| 437 | Anaphylactic shock | 1.9% |
| 438 | Ear Neoplasms | 1.9% |
| 439 | Eyelid Neoplasms | 1.9% |
| 440 | Lung Neoplasms | 1.9% |
| 441 | Pleural Neoplasms | 1.9% |
| 442 | Cell Transformation, Viral | 1.9% |
| 443 | Brain Neoplasms | 1.9% |
| 444 | Salivary Gland Neoplasms | 1.9% |
| 445 | Spinal Cord Neoplasms | 1.9% |
| 446 | Tongue Neoplasms | 1.9% |
| 447 | Uterine Neoplasms | 1.8% |
| 448 | Vaginal Neoplasms | 1.8% |
| 449 | Vulvar Neoplasms | 1.8% |
| 450 | Uterine Cancer | 1.8% |
| 451 | Fallopian Tube Neoplasms | 1.8% |
| 452 | Anemia, Sickle Cell | 1.8% |
| 453 | Thalassemia | 1.8% |
| 454 | Zollinger-Ellison syndrome | 1.8% |
| 455 | Respiratory Hypersensitivity | 1.7% |
| 456 | Pharyngeal Neoplasms | 1.7% |
| 457 | Anemia, Neonatal | 1.6% |
| 458 | Leukocytosis | 1.6% |
| 459 | Pelger-Huet Anomaly | 1.6% |
| 460 | Sick Building Syndrome | 1.6% |
| 461 | Pleocytosis | 1.6% |
| 462 | Multiple Chemical Sensitivity | 1.6% |
| 463 | Central Nervous System Cysts | 1.6% |
| 464 | Bile Duct Neoplasms | 1.6% |
| 465 | gallbladder neoplasm | 1.6% |
| 466 | Intestinal Neoplasms | 1.6% |
| 467 | Penile Neoplasms | 1.6% |
| 468 | Prostatic Neoplasms | 1.6% |
| 469 | Stomach Neoplasms | 1.6% |
| 470 | Urticaria | 1.6% |
| 471 | Vasculitis, Leukocytoclastic, Cutaneous | 1.6% |
| 472 | HTLV-I Infections | 1.6% |
| 473 | Meningeal Carcinomatosis | 1.6% |
| 474 | Ataxia Telangiectasia | 1.5% |
| 475 | Laryngeal neoplasm | 1.5% |
| 476 | Bladder Neoplasm | 1.4% |
| 477 | Kidney Neoplasm | 1.4% |
| 478 | Ureteral Neoplasms | 1.4% |
| 479 | Urethral Neoplasms | 1.4% |
| 480 | Purpura, Hyperglobulinemic | 1.4% |
| 481 | Myasthenia Gravis | 1.4% |
| 482 | Uveomeningoencephalitic Syndrome | 1.4% |
| 483 | Hemolytic-Uremic Syndrome | 1.4% |
| 484 | Bronchial Neoplasms | 1.4% |
| 485 | Drug Eruptions | 1.4% |
| 486 | Ecchymosis | 1.4% |
| 487 | Petechiae | 1.4% |
| 488 | Purpura | 1.4% |
| 489 | Multiple Pulmonary Nodules | 1.4% |
| 490 | Granulomatosis with polyangiitis | 1.4% |
| 491 | Dermatitis, Allergic Contact | 1.4% |
| 492 | HIV Seropositivity | 1.4% |
| 493 | Supratentorial Neoplasms | 1.4% |
| 494 | Endometrial Neoplasms | 1.4% |
| 495 | Sickle Cell Trait | 1.3% |
| 496 | Myasthenia Gravis, Autoimmune, Experimental | 1.3% |
| 497 | Primary Myelofibrosis | 1.3% |
| 498 | Agranulocytosis | 1.3% |
| 499 | Anemia, Megaloblastic | 1.3% |
| 500 | Lymphocytosis | 1.3% |
| 501 | Myelofibrosis | 1.3% |
| 502 | Myeloid Metaplasia | 1.3% |
| 503 | Milk Allergy | 1.3% |
| 504 | Hypoalbuminemia | 1.3% |
| 505 | Wheat Hypersensitivity | 1.3% |
| 506 | Hypereosinophilic syndrome | 1.3% |
| 507 | bone marrow fibrosis | 1.3% |
| 508 | Thrombotic Microangiopathies | 1.3% |
| 509 | Stiff-Person Syndrome | 1.3% |
| 510 | Polyradiculoneuropathy | 1.2% |
| 511 | Polyradiculoneuritis | 1.2% |
| 512 | Waterhouse-Friderichsen Syndrome | 1.2% |
| 513 | Acquired Immunodeficiency Syndrome | 1.2% |
| 514 | AIDS related complex | 1.2% |
| 515 | Hypopharyngeal Neoplasms | 1.2% |
| 516 | Pleural Effusion, Malignant | 1.2% |
| 517 | Hypopharyngeal Cancer | 1.2% |
| 518 | Felty Syndrome | 1.2% |
| 519 | Fanconi Anemia | 1.2% |
| 520 | Lupus Nephritis | 1.2% |
| 521 | Parotid Neoplasms | 1.2% |
| 522 | Prostatic Neoplasms, Castration-Resistant | 1.2% |
| 523 | Nelson Syndrome | 1.2% |
| 524 | Brain Stem Neoplasms | 1.1% |
| 525 | AIDS-Related Opportunistic Infections | 1.1% |
| 526 | Vasculitis, Central Nervous System | 1.1% |
| 527 | Atypical Hemolytic Uremic Syndrome | 1.1% |
| 528 | Dermatitis, Atopic | 1.1% |
| 529 | HIV Wasting Syndrome | 1.1% |
| 530 | Rheumatoid Vasculitis | 1.1% |
| 531 | AIDS Dementia Complex | 1.1% |
| 532 | AIDS-Associated Nephropathy | 1.1% |
| 533 | Lupus Vasculitis, Central Nervous System | 1.1% |
| 534 | Cecal Neoplasms | 1.1% |
| 535 | Duodenal Neoplasms | 1.1% |
| 536 | Acute Chest Syndrome | 1.1% |
| 537 | Choroid Plexus Papilloma | 1% |
| 538 | Niemann-Pick Disease, Type C | 1% |
| 539 | Tonsillar Neoplasms | 1% |
| 540 | Cerebellar Neoplasms | 1% |
| 541 | Nasopharyngeal Neoplasms | 1% |
| 542 | Sicca Syndrome | 1% |
| 543 | Sjogren's Syndrome | 1% |
| 544 | HIV-Associated Lipodystrophy Syndrome | 1% |
| 545 | Colorectal Neoplasms | 1% |
| 546 | Neutropenia | 1% |
| 547 | Neuromyelitis Optica | 0.9% |
| 548 | Leukoencephalitis, Acute Hemorrhagic | 0.9% |
| 549 | Eosinophilia-Myalgia Syndrome | 0.9% |
| 550 | Angioedema | 0.9% |
| 551 | Multiple Sclerosis | 0.9% |
| 552 | Shwartzman Phenomenon | 0.9% |
| 553 | Scurvy | 0.9% |
| 554 | Purpura Fulminans | 0.9% |
| 555 | Acute Generalized Exanthematous Pustulosis | 0.9% |
| 556 | Paranasal Sinus Neoplasms | 0.9% |
| 557 | Radicular Cyst | 0.9% |
| 558 | Appendiceal Neoplasms | 0.9% |
| 559 | Colonic Neoplasms | 0.9% |
| 560 | Rectal Neoplasms | 0.9% |
| 561 | Asthma | 0.8% |
| 562 | Pulmonary Eosinophilia | 0.8% |
| 563 | Eosinophilic Pneumonia | 0.8% |
| 564 | Encephalomyelitis, Acute Disseminated | 0.8% |
| 565 | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | 0.8% |
| 566 | Erythema Nodosum | 0.8% |
| 567 | Neuritis, Autoimmune, Experimental | 0.8% |
| 568 | Dermatitis, Photoallergic | 0.8% |
| 569 | Febrile Neutropenia | 0.8% |
| 570 | Anemia, Pernicious | 0.8% |
| 571 | Maxillary Sinus Neoplasms | 0.7% |
| 572 | Aspergillosis, Allergic Bronchopulmonary | 0.7% |
| 573 | Guillain-Barre Syndrome | 0.7% |
| 574 | Anus Neoplasms | 0.7% |
| 575 | Sigmoid Neoplasms | 0.7% |
| 576 | Asthma, Exercise-Induced | 0.7% |
| 577 | Status Asthmaticus | 0.7% |
| 578 | Multiple Sclerosis, Chronic Progressive | 0.7% |
| 579 | Multiple Sclerosis, Relapsing-Remitting | 0.7% |
| 580 | Toxic Epidermal Necrolysis | 0.6% |
| 581 | Stevens-Johnson Syndrome | 0.6% |
| 582 | Asthma, Occupational | 0.6% |
| 583 | Farmer's Lung | 0.6% |
| 584 | Angioedemas, Hereditary | 0.6% |
| 585 | Hay fever | 0.6% |
| 586 | Rhinitis, Allergic, Perennial | 0.6% |
| 587 | Pseudoxanthoma Elasticum | 0.6% |
| 588 | Giant Cell Arteritis | 0.6% |
| 589 | Temporal Arteritis | 0.6% |
| 590 | Hereditary Angioedema Type III | 0.6% |
| 591 | Hereditary Angioedema Types I and II | 0.6% |
| 592 | Miller Fisher Syndrome | 0.4% |